Literature DB >> 8274926

Summary of 1993 World Health Organisation-International Society of Hypertension guidelines for the management of mild hypertension. Subcommittee of WHO/ISH Mild Hypertension Liaison committee.

.   

Abstract

As part of the ongoing process of issuing guidelines for managing hypertension the World Health Organisation and International Society of Hypertension present a summary of the latest guidelines for the management of mild hypertension. In both young and elderly people this condition is a risk factor for cardiovascular disease and should be treated. Information is presented on methods of diagnostic evaluation and assessment of risk. Methods of treatment, including changes in lifestyle, are covered.

Entities:  

Mesh:

Year:  1993        PMID: 8274926      PMCID: PMC1679536          DOI: 10.1136/bmj.307.6918.1541

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

Review 1.  Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage.

Authors:  A Zanchetti
Journal:  Blood Press       Date:  1992-12       Impact factor: 2.835

Review 2.  Hypertension.

Authors:  J G Evans; G Rose
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

3.  Further analyses of mortality in oral contraceptive users. Royal College of General Practitioners' Oral Contraception Study.

Authors: 
Journal:  Lancet       Date:  1981-03-07       Impact factor: 79.321

4.  Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

Authors:  B Dahlöf; L H Lindholm; L Hansson; B Scherstén; T Ekbom; P O Wester
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

5.  Blood pressure changes: oestrogens in climacteric women.

Authors:  B G Wren; D A Routledge
Journal:  Med J Aust       Date:  1981-11-14       Impact factor: 7.738

6.  Perspectives on systolic hypertension. The Framingham study.

Authors:  W B Kannel; T R Dawber; D L McGee
Journal:  Circulation       Date:  1980-06       Impact factor: 29.690

7.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

8.  White coat hypertension: a follow-up.

Authors:  S Julius; K Jamerson; T Gudbrandsson; N Schork
Journal:  Clin Exp Hypertens A       Date:  1992

9.  The Hypertension Optimal Treatment Study (the HOT Study).

Authors: 
Journal:  Blood Press       Date:  1993-03       Impact factor: 2.835

10.  Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.

Authors:  M J Koren; R B Devereux; P N Casale; D D Savage; J H Laragh
Journal:  Ann Intern Med       Date:  1991-03-01       Impact factor: 25.391

View more
  21 in total

1.  Legal and political considerations of clinical practice guidelines.

Authors:  B Hurwitz
Journal:  BMJ       Date:  1999-03-06

2.  Overall obesity and abdominal obesity and the risk of metabolic abnormalities.

Authors:  S W Lai; K C Ng
Journal:  Ir J Med Sci       Date:  2004 Oct-Dec       Impact factor: 1.568

3.  Effective audit in general practice: a method for systematically developing audit protocols containing evidence-based review criteria.

Authors:  R C Fraser; K Khunti; R Baker; M Lakhani
Journal:  Br J Gen Pract       Date:  1997-11       Impact factor: 5.386

4.  Epidemiological issues in health needs assessment.

Authors:  R Williams; J Wright
Journal:  BMJ       Date:  1998-05-02

Review 5.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

6.  When should essential hypertension in childhood be treated and how?

Authors:  C Loirat
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 7.  Guidelines for the treatment of hypertension: a critical review.

Authors:  J I Robertson
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

8.  Differences of blood pressure estimates between consecutive measurements on one occasion: implications for inter-study comparability of epidemiologic studies.

Authors:  M B Schulze; A Kroke; M M Bergmann; H Boeing
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 9.  Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.

Authors:  J C Gillis; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 10.  [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].

Authors:  A Krivitzky; G Nguyen; Y Gaudouen; M Legrand; R Cohen
Journal:  Drugs       Date:  1998       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.